Results
|
|
27181.
|
Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients. [electronic resource] by
- Rossignol, Alexis
- Levescot, Anaïs
- Jacomet, Florence
- Robin, Aurélie
- Basbous, Sara
- Giraud, Christine
- Roy, Lydia
- Guilhot, François
- Turhan, Ali G
- Barra, Anne
- Herbelin, André
- Gombert, Jean-Marc
Producer: 20121121
In:
European journal of immunology vol. 42
Availability: No items available.
|
|
|
27182.
|
|
|
|
27183.
|
PROPEL: a randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patients. [electronic resource] by
- Wedemeyer, Heiner
- Jensen, Donald
- Herring, Robert
- Ferenci, Peter
- Ma, Mang-Ming
- Zeuzem, Stefan
- Rodriguez-Torres, Maribel
- Bzowej, Natalie
- Pockros, Paul
- Vierling, John
- Ipe, David
- Munson, Marie Lou
- Chen, Ya-Chi
- Najera, Isabel
- Thommes, James
Producer: 20140116
In:
Hepatology (Baltimore, Md.) vol. 58
Availability: No items available.
|
|
|
27184.
|
JUMP-C: a randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patients. [electronic resource] by
- Pockros, Paul J
- Jensen, Donald
- Tsai, Naoky
- Taylor, Ryan
- Ramji, Alnoor
- Cooper, Curtis
- Dickson, Rolland
- Tice, Alan
- Kulkarni, Rohit
- Vierling, John M
- Lou Munson, Marie
- Chen, Ya-Chi
- Najera, Isabel
- Thommes, James
Producer: 20140116
In:
Hepatology (Baltimore, Md.) vol. 58
Availability: No items available.
|
|
|
27185.
|
|
|
|
27186.
|
|
|
|
27187.
|
Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan. [electronic resource] by
- Suzuki, Fumitaka
- Arase, Yasuji
- Suzuki, Yoshiyuki
- Akuta, Norio
- Sezaki, Hitomi
- Seko, Yuya
- Kawamura, Yusuke
- Hosaka, Tetsuya
- Kobayashi, Masahiro
- Saito, Satoshi
- Ikeda, Kenji
- Kobayashi, Mariko
- Kumada, Hiromitsu
Producer: 20130409
In:
Journal of gastroenterology vol. 47
Availability: No items available.
|
|
|
27188.
|
|
|
|
27189.
|
Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C. [electronic resource] by
- Christensen, Peer Brehm
- Krarup, Henrik Bygum
- Laursen, Alex Lund
- Madsen, Poul Henning
- Pedersen, Court
- Schlichting, Poul
- Orholm, Marianne
- Ring-Larsen, Helmer
- Bukh, Jens
- Krogsgaard, Kim
Producer: 20130322
In:
Scandinavian journal of gastroenterology vol. 47
Availability: No items available.
|
|
|
27190.
|
|
|
|
27191.
|
|
|
|
27192.
|
Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes. [electronic resource] by
- Takano, Takashi
- Tsukiyama-Kohara, Kyoko
- Hayashi, Masahiro
- Hirata, Yuichi
- Satoh, Masaaki
- Tokunaga, Yuko
- Tateno, Chise
- Hayashi, Yukiko
- Hishima, Tsunekazu
- Funata, Nobuaki
- Sudoh, Masayuki
- Kohara, Michinori
Producer: 20120123
In:
Journal of hepatology vol. 55
Availability: No items available.
|
|
|
27193.
|
|
|
|
27194.
|
β-Defensin 2 and 3 promote the uptake of self or CpG DNA, enhance IFN-α production by human plasmacytoid dendritic cells, and promote inflammation. [electronic resource] by
- Tewary, Poonam
- de la Rosa, Gonzalo
- Sharma, Neeraj
- Rodriguez, Luis G
- Tarasov, Sergey G
- Howard, O M Zack
- Shirota, Hidekazu
- Steinhagen, Folkert
- Klinman, Dennis M
- Yang, De
- Oppenheim, Joost J
Producer: 20130918
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 191
Availability: No items available.
|
|
|
27195.
|
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA. [electronic resource] by
- Grint, D
- Peters, L
- Schwarze-Zander, C
- Beniowski, M
- Pradier, C
- Battegay, M
- Jevtovic, D
- Soriano, V
- Lundgren, J D
- Rockstroh, J K
- Kirk, O
- Mocroft, A
Producer: 20140307
In:
HIV medicine vol. 14
Availability: No items available.
|
|
|
27196.
|
|
|
|
27197.
|
Simeprevir with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial. [electronic resource] by
- Hayashi, Norio
- Izumi, Namiki
- Kumada, Hiromitsu
- Okanoue, Takeshi
- Tsubouchi, Hirohito
- Yatsuhashi, Hiroshi
- Kato, Mai
- Ki, Rito
- Komada, Yuji
- Seto, Chiharu
- Goto, Shoichiro
Producer: 20150811
In:
Journal of hepatology vol. 61
Availability: No items available.
|
|
|
27198.
|
Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C. [electronic resource] by
- Buti, Maria
- Agarwal, Kosh
- Horsmans, Yves
- Sievert, William
- Janczewska, Ewa
- Zeuzem, Stefan
- Nyberg, Lisa
- Brown, Robert S
- Hézode, Christophe
- Rizzetto, Mario
- Paraná, Raymundo
- De Meyer, Sandra
- De Masi, Ralph
- Luo, Donghan
- Bertelsen, Kirk
- Witek, James
Producer: 20140527
In:
Gastroenterology vol. 146
Availability: No items available.
|
|
|
27199.
|
A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa-2a (40kD)/ribavirin. [electronic resource] by
- Ferenci, Peter
- Aires, Rodrigo
- Ancuta, Ioan
- Arohnson, Andrew
- Cheinquer, Hugo
- Delic, Dragan
- Gschwantler, Michael
- Larrey, Dominique
- Tallarico, Ludovico
- Schmitz, Manuela
- Tatsch, Fernando
- Ouzan, Denis
Producer: 20150615
In:
Liver international : official journal of the International Association for the Study of the Liver vol. 34
Availability: No items available.
|
|
|
27200.
|
Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infection. [electronic resource] by
- Werner, Jens M
- Serti, Elisavet
- Chepa-Lotrea, Xenia
- Stoltzfus, Jonathan
- Ahlenstiel, Golo
- Noureddin, Mazen
- Feld, Jordan J
- Liang, T Jake
- Rotman, Yaron
- Rehermann, Barbara
Producer: 20150511
In:
Hepatology (Baltimore, Md.) vol. 60
Availability: No items available.
|